State Of Wyoming Regeneron Pharmaceuticals, Inc. Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $115,701 - $155,895	-211 Reduced 59.77%	142 $84,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $40,468 - $47,493	68 Added 23.86%	353 $247,000
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $19,021 - $23,483	35 Added 14.0%	285 $180,000
Q3 2021 Feb 14, 2022	BUY	$574.03 - $680.96 $59,125 - $70,138	103 Added 70.07%	250 $151,000
Q3 2021 Feb 11, 2022	SELL	$574.03 - $680.96 $2,296 - $2,723	-4 Reduced 2.65%	147 $89,000
Q2 2021 Feb 11, 2022	SELL	$472.8 - $558.54 $53,899 - $63,673	-114 Reduced 43.02%	151 $84,000
Q1 2021 Feb 08, 2022	BUY	$446.73 - $548.2 $118,383 - $145,273	265 New	265 $125,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.